Dipna Pharmachem Limited became the 389th company to get listed on the BSE SME. Dipna Pharmachem Limited became the 389th company to get listed on the BSE SME Platform on September 08, 2022. Dipna Pharmachem Limited came out with an initial public offering of 40,02,000 Equity Shares of Rs.10 each (“Equity Shares”) for cash at a price of Rs. 38 per equity share (The “Offer Price”), aggregating to Rs. 15.21 crore. The company has successfully completed its public issue on August 30, 2022.
Dipna Pharmachem Limited is Gujarat based company whose registered office is at Ahmedabad. The company engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company’s product portfolio comprises 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti – Bacteria, Quinolones, Veterinary, Anti – Virus, Anti – Inflammatory, Neuropsychiatry, Steroid Hormone, other etc.
Interactive Financial Services Limited, was the lead manager to Dipna Pharmachem Limited.
So far, 150 companies have migrated to the main board. The 388 companies listed on BSE SME Platform have raised Rs.4,201 crore from the market and total market capitalization of 388 companies as on September 07, 2022 is Rs. 59,000 Crore. BSE is the market leader in this segment with a market share of 61 percent.
SEBI came out with detailed guidelines on 18th May 2010 for launching of SME Exchange/Platform. BSE became the first stock exchange to get the approval from SEBI and launch its SME platform on 13th March 2012. The response since the launch of this platform by BSE has been very positive till date.